BHUVANESHWAR: Preparations are being done at a hospital here for the initiating the second phase of human clinical trial of ‘COVAXIN’, India’s autochthonous COVID-19 vaccine.
“The Phase I of the trial is still continuing as we are planning for the start of the Phase II trial shortly,” said Dr E Venkata Rao, Principal Investigator of the trial at Institute of Medical Sciences and SUM Hospital, faculty of medical sciences.
“Two doses of the vaccine were administered to each volunteer after they were selected through a screening process conducted over a period of three to seven days prior to vaccination. The first dose was administered on Day Zero while the blood sample was collected. The second dose was given on Day 14 and the blood sample was also collected,” said Dr Rao.
Janet Elizabeth John@samacharline